Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Berkshire Hathaway Inc. (BRK.A) Fined $900,000 For Failure To Report Transaction

Even firms as big as Berkshire Hathaway Inc. (NYSE:BRK.A) don’t learn from their past mistakes. This was proved when Warren Buffett‘s Berkshire Hathaway Inc.(NYSE:BRK.A) was fined $900,000 by the US Department of Justice for failure to report a transaction recently, which is its second such ‘mistake’ in last six months. Bertha Coombs reported on Berkshire Hathaway Inc. (NYSE:BRK.A)’s fine on CNBC, recently.

Top 4 Strengths a Successful Entrepreneur Needs

“This is a civil fine, Berkshire Hathaway Inc. (NYSE:BRK.A) has agreed to pay nearly $900,000 in conjunction with failure to report a transaction that boosted its stake in  building products firm USG. Warren Buffett in a note says, “we made a mistake when we overlooked the filing requirement. Berkshire Hathaway Inc. (NYSE:BRK.A) had owned convertible notes of USG since 2008 and was effectively forced to convert the notes when they were called for redemption by USG in December of 2013. This event triggered a filing requirement for Berkshire Hathaway Inc. (NYSE:BRK.A) and we were late in realizing that fact”,” Coombs said.

Disclosure: None

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!